abstract |
Mycobacterium tuberculosis (5R) -3- [4- [1-[(2S) -2,3-dihydroxypropanoyl] -3,6-dihydro-2H-pyridine-4 for use in the treatment of tuberculosi s) -Yl] -3,5-difluoro-phenyl] -5- (isoxazol-3-yloxymethyl) oxazolidin-2-one or a pharmaceutically acceptable salt or in vivo-hydrolyzable ester thereof. |